![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Cytovance and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and...
Cytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen...
J&J collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate manufacturing
Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson...
GSK allies with Innovax for COVID-19 vaccine R&D project
GlaxoSmithKline has teamed up with Xiamen Innovax Biotech to evaluate a vaccine against the novel...
Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
Gilead Sciences has been ramping up production of its experimental remdesivir treatment that is being...
Sense, Phillips-Medisize partner to speed up production of new COVID-19 test
Sense has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic...
Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site...
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and...
CDMO to invest over €3m in GMP facility expansion
Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2...
Sterling Pharma Solutions invests $1.5m into US facility expansion
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1.5m into a...
Covance Unveils New R&D Center in Shanghai
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care,...
Sharp’s Netherlands Facility Approved for Clinical Operations
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical...